EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC 4.0

Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”

Therapeutic Advances in Psychopharmacology · 2026-05 · 16

DOI: 10.1177/20451253261452482 ↗

Kurz gefasst

Korrektur in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 19.05.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[This corrects the article DOI: 10.1177/20451253261437597.].

Zitieren

APA

(2026). Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261452482

Vancouver

Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261452482

BibTeX
@article{euvimed2026,
  title = {Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”},
  journal = {Therapeutic Advances in Psychopharmacology},
  year = {2026},
  volume = {16},
  doi = {10.1177/20451253261452482}
}
Kostenlos starten →